DEA Adds Four New Synthetic Opioids to Schedule I
Published Date: 7/1/2026
Proposed Rule
Summary
Starting July 1, 2026, the DEA is temporarily putting four new substances—5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N-propionitrile chlorphine, and spirochlorphine—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move helps keep these potentially dangerous drugs off the streets while the DEA studies them further.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
Temporary Schedule I listing for four opioids
The DEA intends to place four synthetic opioids (5,6-dichloro brorphine; 5,6-dichloro desmethylchlorphine; N-propionitrile chlorphine; and spirochlorphine) into Schedule I. When the temporary scheduling order is published (on or after July 31, 2026) these substances will be subject to the regulatory controls and the administrative, civil, and criminal sanctions that apply to Schedule I drugs, and that temporary control will last two years (with a possible one-year extension).
Possession, manufacture, and trade subject to sanctions
Once the DEA publishes the temporary scheduling order (on or after July 31, 2026), possessing, manufacturing, distributing, importing, or exporting these four named substances will be governed by the Schedule I controls and associated administrative, civil, and criminal sanctions. The temporary scheduling remains in effect for two years from the publication date, with a possible one-year extension.
Research and lab work now tightly restricted
If you engage in research, instructional activities, or chemical analysis involving these four substances, those activities will be subject to Schedule I regulatory controls and the associated administrative, civil, and criminal sanctions once the temporary order is published (on or after July 31, 2026). The temporary controls last for two years from publication, with a possible one-year extension while the government completes the regular scheduling process.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-13145 — Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)
Almac Clinical Services Incorp. (ACSI) wants to become an official importer of certain controlled substances, including psilocybin and oxycodone. This affects drug manufacturers and others in the industry who can comment or request a hearing by July 30, 2026. No direct costs are mentioned, but the decision could impact how these substances enter the U.S. market.
2026-13144 — Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Catalent Pharma Solutions wants to become an official importer of some powerful controlled substances like LSD and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by July 30, 2026. This move could impact companies involved in these substances and the government’s control over them.
2026-12653 — Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
The DEA fixed a typo in the official chemical name of bromazolam, a drug they put in the strictest Schedule I category starting March 16, 2026. This correction makes the rules clear for everyone involved, especially law enforcement and drug handlers. No new fees or deadlines, just a clean-up to keep things accurate and official.
2026-12654 — Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
Starting July 24, 2026, O-desmethyltramadol (also called O-DSMT) will be temporarily placed in Schedule I, meaning it’s treated like the most tightly controlled drugs. This affects anyone who makes, sells, studies, or even just possesses it, bringing strict rules and penalties. The move aims to keep people safe while the government studies the drug more closely.
Previous / Next Documents
Previous: 2026-13302 — Integrated Low-Level Radioactive Waste Disposal
The Nuclear Regulatory Commission is updating rules for disposing of low-level radioactive waste, making it safer and more flexible. This affects waste disposal sites, which will now follow a smarter, risk-based system tailored to their specific conditions. Comments on these changes are open until August 17, 2026, giving everyone a chance to weigh in before new rules roll out.
Next: 2026-13365 — Airworthiness Directives; MD Helicopters, LLC Helicopters
The FAA wants owners of certain MD Helicopters models to check their main transmission drive shaft couplings for cracks. If cracks are found, the couplings must be replaced to keep flights safe. Comments on this plan are open until August 17, 2026, and the inspection is a one-time fix that helps avoid costly repairs or accidents later.